IFNA1 and acquired polycythemia vera: In low-risk PV, phlebotomy and low-dose aspirin are recommended, while high-risk patients should also receive cytotoxic therapy, including Hydroxyurea (HU-in all patients), Interferon-alpha (IFN-in younger patients) and Busulfan (BUS-in the elderly).